Therefore, inhibition of CXCR4 receptor may have therapeutic potential by selectively reducing angiogenic vascular density and delaying the maturation of CD105+ tumor micro-vessels essential for supplying the aggressive cancer phenotypes. This evidence concerns the gene ENG and cancer.